Odyssey Health, Inc.
Cash Flow Statement
| Line Item | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $765.9K | $-3.6M | $-483.4K | $-251.9K | $-251.7K | $-220.1K | $-1.0M | $-12.7M |
| Depreciation & Amortization | — | — | — | — | $0 | $0 | $0 | $0 |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | $0 |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $11.8K | $36.1K | $60.5K | $-473.8K |
| Net Cash from Operating Activities | $-318.5K | $-284.3K | $-284.0K | $-48.2K | $-4.0K | $-46.7K | $-248.5K | $-63.6K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $875.0K | $290.5K | $-5.7K | $0 | $0 | $300.0K | $0 |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |